SGHT Sight Sciences Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: SGHT

Price (delayed)

$8.5

Market cap

$468.25M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.56

Enterprise value

$429.27M

?
Relative Growth: Rel. Growth: 64
Relative Strength: Rel. Strength: 95
Relative Valuation: Rel. Valuation: 11
Relative Profitability: Rel. Profitability: 37
Highlights
Sight Sciences's EPS has increased by 42% YoY and by 21% from the previous quarter
The net income has grown by 39% YoY and by 20% from the previous quarter
The quick ratio has plunged by 52% YoY and by 15% from the previous quarter
Sight Sciences's equity has decreased by 24% YoY
Sector: Healthcare
Industry: Medical Devices
Website: https://www.sightsciences.com
Peers: OFIX

Key stats

What are the main financial stats of SGHT

SGHT stock price

How has the Sight Sciences stock price performed over time
Intraday
-1.05%
1 week
4.42%
1 month
2.91%
1 year
141.48%
YTD
7.19%
QTD
56.83%

Financial performance

How have Sight Sciences's revenue and profit performed over time
Revenue
$83.38M
Gross profit
$73.34M
Operating income
-$27.88M
Net income
-$29.76M
Gross margin
88%
Net margin
-35.7%
The operating margin is up by 48% year-on-year and by 25% since the previous quarter
SGHT's net margin is up by 44% year-on-year and by 24% since the previous quarter
SGHT's operating income is up by 43% year-on-year and by 22% since the previous quarter
The net income has grown by 39% YoY and by 20% from the previous quarter

Price vs fundamentals

How does SGHT's price correlate with its fundamentals

Growth

What is Sight Sciences's growth rate over time

Valuation

What is Sight Sciences stock price valuation
P/E
N/A
P/B
8.74
P/S
5.56
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
5.15
Sight Sciences's EPS has increased by 42% YoY and by 21% from the previous quarter
The stock's P/B is 185% more than its 5-year quarterly average of 3.1 and 88% more than its last 4 quarters average of 4.7
Sight Sciences's equity has decreased by 24% YoY
The stock's price to sales (P/S) is 61% more than its last 4 quarters average of 3.5 and 4.1% more than its 5-year quarterly average of 5.4
The revenue is up by 9% YoY and by 4.8% from the previous quarter

Efficiency

How efficient is Sight Sciences business performance
Sight Sciences's ROS has increased by 49% YoY and by 27% from the previous quarter
The company's return on invested capital rose by 46% YoY and by 22% QoQ
The ROA is up by 27% year-on-year and by 17% since the previous quarter
The company's return on equity rose by 15% YoY and by 14% QoQ

Dividends

What is SGHT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for SGHT.

Financial health

How did Sight Sciences financials performed over time
The total assets is 102% more than the total liabilities
The quick ratio has plunged by 52% YoY and by 15% from the previous quarter
Sight Sciences's current ratio has shrunk by 51% YoY and by 16% QoQ
SGHT's debt is 23% smaller than its equity
SGHT's debt to equity is up by 35% year-on-year and by 2.7% since the previous quarter
Sight Sciences's equity has decreased by 24% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.